New Biotech Offering Targets $426B Rare Disease Market
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
About International Business Machines Corp
International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. Its Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. Its Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. It has strategic partnership with various companies, including hyperscalers, service providers, system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.
General
| Name | International Business Machines Corp |
| Ticker | IBM |
| Exchange | NYSE |
| Sector | Technology |
| Industry | Information Technology Services |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 270,300 |
Highlights
| Analyst Target | 286.12 |
| Market Cap | 267,085,200,000 |
| PE Ratio | 46.51 |
| PEG Ratio | 1.72 |
| EBITDA | 14,183,000,064 |
Share Stats
| Shares Outstanding | 931,520,000 |
| Shares Float | 930,600,000 |
| Shares Short | 14,630,000 |
| Insider Holdings | 12% |
| Institution Holdings | 65.08% |
Highlights
| Analyst Target | 286.12 |
| Market Cap | 267,085,200,000 |
| PE Ratio | 46.51 |
| PEG Ratio | 1.72 |
| EBITDA | 14,183,000,064 |
Valuation
| Trailing PE | 45.84 |
| Forward PE | 23.75 |
| Price/Sales (Trailing 12 Mt.) | 4.17 |
| Price/Book (Most Recent Quarter) | 9.63 |
Dividend
International Business Machines Corp pays out a dividend of $6.70 per share, with a dividend yield of 2.34%.
IBM's last dividend payment was made to shareholders on September 10, 2025.
They pay out 103.78% of their earnings out as a dividend.
Recent Dividends
| Sep 10, 2025 | $1.68 |
| Jun 10, 2025 | $1.68 |
| Mar 10, 2025 | $1.67 |
| Dec 10, 2024 | $1.67 |
| Sep 10, 2024 | $1.67 |
| Jun 10, 2024 | $1.67 |
| Mar 9, 2024 | $1.66 |
| Dec 9, 2023 | $1.66 |
Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline
According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.
Ondas Holdings Stock Is Hitting New 52-Week Highs Today: Here's Why
Shares of Ondas Holdings Inc. (NASDAQ: ONDS) are soaring Thursday after the autonomous drone infrastructure company said it placed a significant purchase order.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Trump files $15 billion defamation lawsuit against The New York Times
NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.
3 Gold Mining Stocks Shine As Prices Hit Records
Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Consumer Tech News (Sep. 15 – Sep. 19): Fed Rate Cut Lifts Wall Street To Records As Meta Unveils Smart Glasses, Nvidia-Intel Forge Chip Pact
Wall Street rallied to record highs after the Fed's rate cut, while Meta launched new smart glasses, Nvidia teamed with Intel on chips, and big names like General Mills, FedEx, and Darden reported earnings.
BlackRock Turns Popular Mutual Funds Into Global Equity ETFs
BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Opendoor Stock Rallies On Expansion And Short Squeeze Hopes
Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.
It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant
ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Trump Admin Pushes G7, EU To Slap Tariffs On China And India Over Russian Oil Purchase To 'End The Senseless Killing' In Ukraine
The U.S. is pressing G7 and EU allies to impose tariffs on China and India for buying Russian oil, while Trump's trade war policies have driven tariff revenues to a record $30 billion in August.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
How the Multiplier Effect is Working on This $3 Crypto - Ad
It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.
Elon Musk's $1 Trillion Pay Package Is 'A Little Bit Weird' To Compare Monetarily, Says Tesla Board Chair: It's About 'Voting Influence'
Tesla's board chair, Robyn Denholm, defended Elon Musk's $1 trillion compensation package, emphasizing its potential to drive unique performance despite recent sales struggles.
Bitcoin Unmoved By Fed Rate Cut; Ethereum, XRP, Dogecoin Spike: Analyst Says BTC Should See $120,000 By End Of Week If 'All Goes To Plan'
Bitcoin failed to break out of its range, but other major coins rose on Wednesday as the Federal Reserve implemented its first interest rate cut of the year.
Want To Know the No.1 Crypto and the No.1 Stock? - Ad
The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.
AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why
AquaBounty Technologies saw a massive 98.25% surge in after-hours trading to $2.26, following confirmation that it had met NASDAQ's minimum bid price requirement, resolving its earlier delisting risk.
Trump Links Sanctions On Russia To NATO Unity, Calls Out Hungary And Slovakia Over Oil Purchases
Trump stated that sanctions on Russia would only be imposed if all NATO countries agree to identical measures and halt Russian oil purchases.
Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad
If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."
Palantir's 100x Revenue Multiple 'Inspired' Billionaire Marc Benioff, Maybe CRM Is 'Not Charging Enough,' Says Salesforce CEO
Salesforce CEO Marc Benioff praised Palantir's market positioning and premium pricing model, despite the size difference between the two companies.
Warner Bros, Oracle, And Micron Technology Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 8 - Sep. 12): Are The Others In Your Portfolio?
Deal buzz, analyst upgrades, and AI momentum drove top weekly gainers—led by Warner Bros., Oracle, and Micron—across large-cap tech and media.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Scam centers are spreading in East Timor, UN report says
BANGKOK (AP) — A suspected scam call operation and a suspicious network of companies was discovered with links to a new free trade zone in East Timor, the U.N. Office of Drugs and Crime said Thursday.
Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO
The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
As controversy swirls around late-night TV, here's what a new poll shows about who still watches
WASHINGTON (AP) — As late-night talk shows undergo major changes and controversy, a new poll finds that while most Americans don't watch them regularly, the ones who do make such programming part of their routine are more likely to be Democrats.
Kevin O'Leary Once Admitted He Wasn't The Best Dad — But The Shark Gave Himself A '10 Out Of 10' Score In One Key Area
Kevin O'Leary admitted he wasn't always present as a father but said financial stability made him a "10 out of 10" provider, sharing how tough-love lessons with his son and sacrifices echoed by Barack Obama and Mark Cuban highlight the trade-offs between family and success.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Trump Admin's Intel Stake Could Create 'Unintended Inefficiencies' In Global Chip Industry, Warns Fitch
The U.S. government's recent investment in Intel Corp. (NASDAQ: INTC) could lead to unintended inefficiencies in the global semiconductor industry, according to a report by Fitch Ratings.
Australia warns social media platforms against age verification for all ahead of a ban on children
MELBOURNE, Australia (AP) — Australian authorities said Tuesday that should not demand age verification for all account holders starting from December, when a having accounts goes into effect in the country.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Crypto Is The Money For AI, Says Economist As Coinbase CEO Teases Stablecoin-Powered Transactions Between Agents
Renowned economist Alex Tabbarok described cryptocurrencies as the “money” for artificial intelligence on Tuesday after Coinbase Global Inc. (NASDAQ:COIN) CEO teased a new feature that enables AI agents to transact using stablecoins.
Trump Warns Of Massive Debt, Peter Grandich Warns Of 'Most Dangerous Time in 40 Years,' Fed Trapped In Inflation And More: This Week In Economy
Peter Grandich warns that we're in the "most dangerous time in 40 years," as gold surges and the Fed faces challenges with inflation and unemployment.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust
WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.
Will electric tractors gain traction? At a pilot event for farmers, researchers see possibilities
EAST LANSING, Mich. (AP) — In the soft dirt of an indoor horseback riding ring last month, a group of farmers got ready to test drive a new piece of equipment: an electric tractor.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Why Redwire Stock Is Gaining Today
Redwire climbs about 4% after subsidiary Edge Autonomy wins a European NATO ally contract to supply Stalker Group 2 reconnaissance drone.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.